Evidence map›Paper›PMID 33889517›Full record

ArticleTranslational lung cancer research2021

Ziqi Jia, Jiahua Xing, Ji Li, Weiwei Wang, Yadong Wang, Yang Song, Xiaoying Yang, Jianchao Xue, Junyi Ye, Bing Li and 18 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 11 institutions in 2 countries.

Ziqi JiaDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Jiahua XingSchool of Medicine, Nankai University, Tianjin, China.
Ji LiDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Weiwei WangDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Yadong WangDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Yang SongDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Xiaoying YangDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Jianchao XueDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Junyi YeDepartment of Biostatistics, Burning Rock Biotech Co. Ltd., Guangzhou, China.
Bing LiDepartment of Biostatistics, Burning Rock Biotech Co. Ltd., Guangzhou, China.
Han Han-ZhangDepartment of Medicine, Burning Rock Biotech Co. Ltd., Guangzhou, China.
Jiaxing ZhaoDepartment of Medicine, Burning Rock Biotech Co. Ltd., Guangzhou, China.
Xiaochun ZhangPrecision Medicine Center of Cancer, The Affiliated Hospital of Qingdao University, Qingdao, China.
Feng PengDepartment of Thoracic Cancer, Cancer Center, West China Hospital, S.C.U., Chengdu, China.
Fengxia ChenDepartment of Thoracic Surgery, Hainan General Hospital, Haikou, China.
Xueqin ChenDepartment of Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yan LuDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Shenpeng YingDepartment of Radiotherapy, Taizhou Central Hospital, Affiliated Hospital of Taizhou University, Taizhou, China.
Dongping WuDepartment of Radiation Oncology, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Xinwei ZhangDepartment of Biotherapy, Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.
Caixia MaXtalPi, XtalPi AI Research Center, Beijing, Chinal.
Lipeng LaiXtalPi, XtalPi AI Research Center, Beijing, Chinal.
Songling MaXtalPi, XtalPi AI Research Center, Beijing, Chinal.
Dianjing LiangInstitute of Physics, Humboldt University of Berlin, Berlin, Germany.
Peng LiuMedical Research Center, Central Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Xiaoguang LiMinimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Naixin LiangDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Shanqing LiDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBurning Rock Biotech (China) · CNPeking Union Medical College Hospital · CNAffiliated Hospital of Qingdao University · CNHainan General Hospital · CNNankai University · CNQingdao University · CNTaizhou Central Hospital · CNTianjin Medical University Cancer Institute and Hospital · CNYueyang Hospital · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsAn in-house database of 7,812 LUAD patients was screened for mutation prevalence. A multi-center cohort of 16

resultsIn Chinese LUAD, the prevalence of

conclusionsComapred with non-TMD mtuations,

Indexed as

HER2 mutationlung adenocarcinoma (LUAD)prognosispyrotinibtreatment response

Identifiers

PMID33889517
PMCPMC8044484
OpenAlexW3151764904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.